Vicks VapoRub

Vicks VapoRub ointment is a mentholated topical ointment. VapoRub is indicated for use on the chest, back and throat for cough suppression due to the common cold or on muscles and joints for minor aches and pains. Vicks VapoRub has also been used to treat mosquito bites. Users of VapoRub often apply it immediately before sleep. VapoRub was originally manufactured by the family-owned company Richardson-Vicks, Inc., based in Greensboro, North Carolina.

Richardson-Vicks was sold to Procter & Gamble in 1985 and is now known as Vicks. VapoRub is also currently manufactured and packaged in India and Mexico. In German-speaking countries (the exception of Switzerland) it is sold under the name Wick VapoRub. VapoRub continues to be Vicks's flagship product internationally, and the Vicks brand name is often used synonymously with the VapoRub product.

VapoRub can be inhaled with hot steam. Since VapoRub ointment is an oil-based medication, it should not be used under or inside the nose or inside the mouth, and it should not be swallowed. Any oil-based product can get into the lungs if used improperly.

In pre-clinical animal studies, the application of Vicks VapoRub directly onto the tracheae of ferrets caused an increase in mucus production compared to a water-based lubricant. However, since the authors used a water-based and not oil-based compound as a control, it is not possible to ascertain which component of Vicks VapoRub caused the increased mucus production. Because Vicks VapoRub was also directly applied to the ferret trachea, it is also difficult to extrapolate the results from this study to comment on possible irritation arising from the safe use of Vicks VapoRub in humans.

A Penn State study showed Vicks VapoRub to be more effective than placebo petroleum rub for helping cough and congestion with regards to helping children and even adults sleep. However, the study also showed that, unlike with the petroleum rub placebo, Vicks VapoRub was associated with burning sensations to the skin (28%), nose (14%) and eyes (16%), with 5% of study participants reporting redness and rash when using the product.

...
Wikipedia